Recent epidemiologic studies, most of them in predominantly White populations, have suggested that long duration of oral contraceptive (OC) use may increase the risk of breast cancer at young ages. We assessed the relationship of OC use to the risk of breast cancer in African-American women aged 25 to 59 years, using interview data from a multipurpose hospital-based case-control study. Five hundred and twenty-four cases hospitalized for invasive breast cancer were compared with 1,021 controls with nonmalignant conditions unrelated to OC use. Relative risks (RR) and 95 percent confidence intervals (CI) were estimated relative to a reference category of use for less than 12 months; potential confounders were controlled by multiple logistic regression analysis. Among women under age 45, three or more years of OC use was associated with an increased risk of breast cancer: the RR estimate was 2.8 (CI=1.5–5.0) for three to four years of use, and declined to 1.5 (CI=0.8.3.0) for 10 or more years of use. Recency and timing of use did not explain the observed association. Among women aged 45 to 59, OC use was associated with little or no increase in risk: the RR estimate for three or more years of use was 1.3 (CI=0.7–2.4). The findings add to the evidence from studies of White women and a recent study of Black women which have suggested an increased risk of breast cancer at young ages for moderate or long duration use of OCs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Malone KE, Daling JR, Weiss NS. Oral contraceptives in relation to breast cancer. Epidemiol Rev 1993; 15: 80–97.
Thomas DB. Oral contraceptives and breast cancer: a review of the epidemiologic literature. Contraception 1991; 43: 597–642.
Rookus MA, van Leeuwen FE. Oral contraceptives and risk of breast cancer in women aged 20–54 years. Lancet 1994; 344: 844–51.
White E, Malone KE, Weiss NS, Daling JR. Breast cancer among young U.S. women in relation to oral contraceptive use. JNCI 1994; 86: 505–14.
Bernstein L, Pike MC, Krailo M, Henderson BE. Update of the Los Angeles Study of oral contraceptives and breast cancer. 1981 and 1983. In: Mann RD, ed. Oral contraceptives and breast cancer. London, UK: Royal Society of Medicine, 1990: 169–80.
Meirik O, Lund E, Adami HO, Bergstrom R, Christoffersen T, Bergsio P. Oral contraceptive use and breast cancer in young women. Lancet 1986; ii: 650–53.
McPherson K, Vessey MP, Neil A, Doll R, Jones L, Roberts M. Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer 1987; 56: 653–60.
Olsson H, Moller TR, Ranstam J. Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden. JNCI 1989; 81: 1000–4.
WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Breast cancer and combined oral contraceptives: results from a multinational study. Br J Cancer 1990; 61: 110–9.
UK National Case-control Study Group. Oral contraceptive use and breast cancer risk in young women. Lancet 1989; 6: 973–82.
Weinstein AL, Mahoney MC, Nasca PC, Leske MC, Varma AO. Breast cancer risk and oral contraceptive use: results from a large case-control study. Epidemiology 1991; 2: 353–8.
Meirik O, Farley TM, Lund E, et al. Breast-cancer and oral contraceptives: patterns of risk among parous and nulliparous women-further analysis of the Swedish-Norwegian material. Contrception 1989; 39: 471–5.
Miller DR, Rosenberg L, Kaufman DW, et al. Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol 1989; 129: 269–80.
Rohan TE, McMichael AJ. Oral contraceptive agents and breast cancer: a population-based case-control study. Med J Aust 1988; 149: 520–6.
Clavel F, Andriu N, Gairard B et al. Oral contraceptives and breast cancer: a French case-control study. Int J Epidemiol 1991; 20: 32–8.
Romieu I, Willett WC, Colditz GA, et al. Prospective study of oral contraceptive use and risk of breast cancer in women. JNCI 1989; 81: 1313–21.
National Cancer Institute. SEER Cancer Statistics Review 1973–1991. Bethesda, MD (USA): NCI, June 1994; NIH Pub. No. 94–2789.
White E, Daling JR, Norsted TL, Chu J. Rising incidence of breast cancer among young women in Washington state. JNCI 1987; 79: 239–43.
Gray GE, Henderson BE, Pike MC. Changing ratio of breast cancer incidence rates with age of black females compared with white females in the United States. JNCI 1980; 64: 461–3.
Shapiro S. Case-control surveillance. In: Strom BL, ed. Pharmacoepidemiology. 2nd Edition. New York, NY (USA): John Wiley, 1994.
Schlesselman JJ. Case-control studies: design, conduct, analysis. New York NY (USA): Oxford University Press, 1982.
Miettenen OS. Estimability and estimation in case-referent studies. Am J Epidemiol 1976; 103: 226–35.
Schatzkin A, Palmer JR, Rosenberg L, et al. Risk factors for breast cancer in black women. JNCI 1987; 78: 213–7.
Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15: 36–47.
Daling JR, Malone KE, Voigt LF, White E, Weiss NS. Risk of breast cancer among young women: relationship to induced abortion. JNCI 1994; 86: 1584–92.
Rosenberg L. Induced abortion and breast cancer: more scientific data are needed. JNCI 1994; 86: 156–7.
Mayberry RM. Age-specific patterns of association between breast cancer and risk factors in black women, age 20 to 39 and 40 to 54. Ann Epidemiol 1994; 4: 205–13.
Wingo PA, Lee NC, Ory HW, Beral V, Peterson HB, Rhodes P. Age-specific differences in the relationship between oral contraceptive use and breast cancer. Obstet Gynecol 1991; 78: 161–70.
McPherson K, Drife JO. The Pill and breast cancer: Why the uncertainty? (Editoria) Br Med J [Clin Res Ed] 1986; 293: 709–10.
Gerstman BB, Gross TP, Kennedy DL. Trends in the content and use of oral contraceptives in the United States, 1964–88. Am J Public Health 1991; 81: 90–8.
Krieger N. Social class and the black-white crossover in the age-specific incidence of breast cancer: a study linking census-derived data to population based registry records. Am J Epidmiol 1990; 131: 804–14.
National Center for Health Statistics. Health, United States, 1989. Hyattsville, MD (USA): Public Health Service, 1990; DHHS Pub. No. (PHS) 90–1232.
Stephan EH, Rindfuss RR, Bean FP. Racial differences in contraceptive choice: complexity and implications. Demography 1988; 25: 53–70.
Author information
Authors and Affiliations
Additional information
This research was supported by the US National Cancer Institute (grants R01 CA55766 and R01 CA45762). Additional support was provided by the US Food and Drug Administration (FD-U-000082); the views expressed do not necessarily represent the views of the Food and Drug Administration. The Slone Epidemiology Unit also receives support from Hoffmann-La Roche, Inc., and Marion Merrell Dow Inc.
Rights and permissions
About this article
Cite this article
Palmer, J.R., Rosenberg, L., Rao, R.S. et al. Oral contraceptive use and breast cancer risk among African-American women. Cancer Causes Control 6, 321–331 (1995). https://doi.org/10.1007/BF00051407
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00051407